Keywords: AstraZeneca, Aptium Oncology, Assets sale, Oncology management services, USA

AstraZeneca completes sale of Aptium Oncology assets

Article | 09 July 2012

Print This

Anglo-Swedish drug major AstraZeneca (LSE: AZN) says that it has completed the previously indicated sale of the assets of its ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in